Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Prostate cancer Clinical Trials

Protocol Number Title
2006NT007
Diagnostic Prostate Magnetic Resonance Imaging at 3 Tesla with an Endorectal Coil
2007NT080
Magnetic Resonance Imaging of the Prostate at 7 Tesla
2008NTLS098
Active Surveillance for Men With Low Volume, Early Stage, Screen Detected Prostate Cancer
2011LS109
A Randomized, Double-Blind Phase II Study of Sipuleucel-T (Provenge?) Followed by Indoximod or Placebo in the Treatment of Patients with Asymptomatic or Minimally Symptomatic Metastatic Castration Resistant Prostate Cancer
2013IS016
A Phase IIA Exploratory, Randomized, Placebo-controlled Trial of Pomegranate Fruit Extract/POMx in Subjects with Clinically Localized Prostate Cancer Undergoing Active Surveillance
2015CG094
Molecular Analysis for Therapy Choice (MATCH)
2015CG098
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
2015IS084
A single-arm, phase 2 study to evaluate the safety and efficacy of VT-464 in patients with castration-resistant prostate cancer progressing on enzalutamide or abiraterone
EAY131-N
EAY131-N: MATCH Treatment Subprotocol N: Phase II Study of PI3K Beta Specific Inhibitor, GSK2636771, in Patients with Tumors with PTEN Mutation or Deletion, with PTEN Expression on IHC

9 trials displayed